The FDA’s new medical device guidelines: 4 things to keep in mind

New guidance from the FDA has rolled out covering how medical devices are developed and maintained by their manufacturers. In this article for Chief Healthcare Executive, Phosphorus VP of Product Sonu Shankar writes that this is a significant step and could go a long way toward reducing the risks providers may face.

Nevertheless, it is imperative that providers stay vigilant in safeguarding their patients’ well-being and ensuring the continuity of their operations.

Shankar has written about four important issues to remember. Read his key information on legacy devices, third-party code, time to deliver patches, and device monitoring here at Chief Healthcare Executive.